TAF9 Antikörper (AA 110-160)

Produktnummer ABIN6991978

Produktdetails anti-TAF9 Antikörper

Target: TAF9 (RNA Polymerase II TBP-Associated Factor Subunit G (TAF9))

Bindungsspezifität: AA 110-160

Reaktivität: Human, Ratte, Maus

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser TAF9 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), ELISA, Immunofluorescence (IF), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Spezifität: TAF9 antibody is human, mouse and rat reactive. Multiple isoforms of TAF9 are known to exist. TAF9 is predicted to not cross-react with other TAF family members.

Aufreinigung: TAF9 antibody is affinity chromatography purified via peptide column.

Immunogen: TAF9 antibody was raised against a 17 amino acid peptide near the center of human TAF9. The immunogen is located within amino acids 110 - 160 of TAF9.

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: TAF9 antibody can be used for detection of TAF9 by Western blot at 1 - 2 μ,g/mL. Antibody can also be used for Immunohistochemistry at 5 μ,g/mL. For Immunoflorescence start at 20 μ,g/mL.

Antibody validated: Western Blot in human samples, Immunohistochemistry in mouse samples and Immunofluorescence in mouse samples. All other applications and species not yet tested.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 1 mg/mL

Buffer: TAF9 Antibody is supplied in PBS containing 0.02 % sodium azide.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C,4 °C

Informationen zur Lagerung: TAF9 antibody can be stored at 4°C for three months and -20°C, stable for up to one year.

Details zu TAF9

Target: TAF9 (RNA Polymerase II TBP-Associated Factor Subunit G (TAF9))

Andere Bezeichnung: TAF9 (TAF9 Produkte)

Synonyme: AK6 antikoerper, CGI-137 antikoerper, CINAP antikoerper, CIP antikoerper, MGC:1603 antikoerper, MGC:3647 antikoerper, MGC:5067 antikoerper, TAF2G antikoerper, TAFII31 antikoerper, TAFII32 antikoerper, TAFIID32 antikoerper, hCINAP antikoerper, 2310012M09Rik antikoerper, 2810046E22Rik antikoerper, 4921516M08Rik antikoerper, AA673500 antikoerper, AU045423 antikoerper, Ak6 antikoerper, Taf2g antikoerper, im:7089279 antikoerper, wu:fb16h03 antikoerper, zgc:153410 antikoerper, TATA-box binding protein associated factor 9 antikoerper, adenylate kinase 6 L homeolog antikoerper, adenylate kinase isoenzyme 6-like antikoerper, SAGA complex/ transcription initiation factor Taf9 antikoerper, TAF9 RNA polymerase II, TATA box binding protein (TBP)-associated factor antikoerper, TAF9 antikoerper, Taf9 antikoerper, ak6.L antikoerper, LOC100355082 antikoerper, taf9 antikoerper

Hintergrund: Initiation of transcription by RNA polymerase II is coordinated by the transcription factor IID (TFIID), which binds to the core promoter to position the polymerase properly, serves as the scaffold for assembly of the remainder of the transcription complex, and acts as a channel for regulatory signals. TFIID is composed of the TATA-binding protein (TBP) and the TBP-associated factors (TAFs). TAFs may participate in basal transcription, serve as coactivators, function in promoter recognition or modify general transcription factors (GTFs) to facilitate complex assembly and transcription initiation (1). TAF9 is one of the smaller subunits of TFIID that binds to the basal transcription factor GTF2B as well as to several transcriptional activators such as p53 and VP16 (2).

Molekulargewicht: Predicted: 29 kDa

Observed: 28 kDa

Gen-ID: 6880

NCBI Accession: NP_003178

UniProt: Q16594

Pathways: Negative Regulation of intrinsic apoptotic Signaling